Women's Health Strategic Roundup: Earlier Intervention | Sep 08 – Oct 13, 2026
Women’s health market trends signal a competitive shift toward earlier…
Women’s Health Today—July 8, 2026
This biweekly Women’s health video recap highlights regulatory approvals,…
Innovent-Lilly Verzenios China Commercialization | Lucid Diligence Brief
Innovent takes mainland China commercial responsibility for Verzenios as Lilly…
Women’s Health Today—June 24, 2026
This biweekly Women’s Health video recap highlights funding and care delivery…
Women’s Health Today—June 10, 2026
This biweekly Women’s Health recap highlights regulatory progress, clinical…
Rallybio Avenzo Merger and $215M Financing | Lucid Diligence Brief
Rallybio and Avenzo’s reverse merger puts Nasdaq access, $215M financing and…
ASCO 2026: Competitive Shifts in Oncology
ASCO at a glance ASCO 2026 highlights how oncology innovation is being tested…
Lucid Diligence Brief: AstraZeneca Camizestrant FDA Delay
Lucid Diligence Brief: AstraZeneca Camizestrant FDA Delay Raises SERENA-6…
Women’s Health Today—May 13, 2026
This biweekly Women’s Health video recap highlights regulatory actions,…
Women’s Health Today—April 29, 2026
This biweekly Women’s Health video recap highlights regulatory actions, access…
Vaccines Today—April 3, 2026
This week’s Vaccines Research update highlights regulatory momentum, clinical…
Lucid Diligence Brief: Novartis to acquire Pikavation Therapeutics from Synnovation
Lucid Diligence Brief: Novartis to acquire Pikavation Therapeutics from…
